Insider Transactions in Q3 2022 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Thomas J Klima |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+11.77%
|
-
|
|
Aug 19
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
14,194
-6.97%
|
$70,970
$5.53 P/Share
|
|
Aug 04
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
21,805
-8.11%
|
$87,220
$4.39 P/Share
|
|
Aug 04
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
7,448
-3.53%
|
$29,792
$4.39 P/Share
|
|
Jul 12
2022
|
Anne Virginie Eggimann Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,358
-3.11%
|
$5,432
$4.95 P/Share
|